一名新奥尔良女性使用基因组测试证实她应该继续癌症治疗, A New Orleans woman used a genomic test to confirm she should continue cancer treatment, gaining confidence in her fight.

Adrianne Jouet,42岁的新奥尔良母亲,在常规乳房X光检查发现有可疑的重物后,接受了乳腺癌诊断。 Adrianne Jouet, a 42-year-old New Orleans mother, received a breast cancer diagnosis after a routine mammogram revealed a suspicious mass. 在接受双胞胎切除术和四年荷尔蒙治疗后,她的肿瘤科医生建议将治疗延长至10年。 After a double mastectomy and four years of hormone therapy, her oncologist recommended extending treatment to ten years. 在被副作用压倒的情况下,她寻求进行一个MammaPrinté基因组测试,以评估其复发风险。 Overwhelmed by side effects, she sought a MammaPrint® genomic test to assess her recurrence risk. 测试显示风险较低,证实延长治疗将大大降低其复发的可能性。 The test showed a low risk, confirming that extended therapy would significantly reduce her chance of recurrence. 在有这些证据的情况下,她全心全意地致力于将不确定性转化为信心,并授权她有目的地战斗。 Armed with this evidence, she committed to the full course, transforming uncertainty into confidence and empowering her to fight with purpose.